Virtual Medicinal Product (VMP) - Etranacogene dezaparvovec 100 tera genome copies/10ml solution for infusion vials
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Etranacogene dezaparvovec 100 tera genome copies/10ml solution for infusion vials | Start Date 03-07-2024 | End Date |
| Abbreviated Name | Abbreviated Name Etranacogene dezaparvovec 100 tera genome copies/10ml inf | Start Date 03-07-2024 | |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- B02BD16
| Code | Start Date | End Date |
|---|---|---|
| 43007311000001109 | 03-07-2024 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Etranacogene dezaparvovec | Based on Ingredient Substance | 10 tera genome copies | 1 ml |
Name
Etranacogene dezaparvovec
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
10.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMEtranacogene dezaparvovec
-
VMP(Current) Etranacogene dezaparvovec 100 tera g...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 vial |